Cargando…
Assessing Baseline and Temporal Changes in Cardiometabolic Risk Using Metabolic Syndrome Severity and Common Risk Scores
BACKGROUND: Type 2 diabetes mellitus (T2DM) is considered a cardiovascular disease (CVD) risk equivalent, thereby linking assessment of cardiometabolic risk with that of CVD risk over time. Our goal was to determine how commonly used CVD risk scores and metabolic syndrome (MetS) severity performed i...
Autores principales: | Gurka, Matthew J., Filipp, Stephanie L., Pearson, Thomas A., DeBoer, Mark D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201393/ https://www.ncbi.nlm.nih.gov/pubmed/30369320 http://dx.doi.org/10.1161/JAHA.118.009754 |
Ejemplares similares
-
Use of a Metabolic Syndrome Severity Z Score to Track Risk During Treatment of Prediabetes: An Analysis of the Diabetes Prevention Program
por: DeBoer, Mark D., et al.
Publicado: (2018) -
SUN-064 Associations of a Metabolic Syndrome Severity Score with Future Coronary Heart Disease (CHD) and Diabetes in Fasting vs. Non-Fasting Individuals
por: DeBoer, Mark, et al.
Publicado: (2019) -
Clinical utility of metabolic syndrome severity scores: considerations for practitioners
por: DeBoer, Mark D, et al.
Publicado: (2017) -
Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes
por: Gurka, Matthew J., et al.
Publicado: (2018) -
Geographical variation in the prevalence of obesity, metabolic syndrome, and diabetes among US adults
por: Gurka, Matthew J., et al.
Publicado: (2018)